What does CUSIP 40637H109 represent in this 13F holders report?

CUSIP 40637H109 is the security identifier for HALO - HALOZYME THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in Q1 2020?

205 institutional investors reported HALO - HALOZYME THERAPEUTICS, INC. - Common Stock for Q1 2020. Use the holders table for investor-level position and value details.

HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q1 2020 13F Holders as of 31 Mar 2020

Security type / class: Equity / Common Stock
Total 13F shares: 130,660,067
Total 13F value: $2,348,012,984
Share change: +3,096,691
Put/Call ratio: 66%
SEC-reported price per share: $17.99
Number of holders: 205
Value change: +$56,330,665
Number of buys: 83
Number of sells: 126
Shares outstanding: 118,494,184

Security key

40637H109

Report period

Q1 2020

Institutions

205

Top holders

HALO full security history Ownership snapshot Full 13F holder table HALOZYME THERAPEUTICS, INC. SEC filings HALOZYME THERAPEUTICS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

15/15

Latest evidence

31 Dec 2019

13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Comparable ownership Top 5

VANGUARD GROUP INC 12%

BlackRock Finance, Inc. 10%

Bellevue Group AG 6.8%

Third Security, LLC 5.9%

WILLIAM BLAIR INVESTMENT MANAGEME... 5.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	12%	$248,277,000 14,003,155 shares	—	31 Dec 2019
BlackRock Finance, Inc.	13F Company 13F	10%	$214,477,000 12,096,797 shares	—	31 Dec 2019
Bellevue Group AG	13F Company 13F	6.8%	$142,493,000 8,036,856 shares	—	31 Dec 2019
Third Security, LLC	13F Company 13F	5.9%	$124,932,000 7,046,385 shares	—	31 Dec 2019
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	13F Company 13F	5.3%	$112,258,000 6,331,530 shares	—	31 Dec 2019
Artisan Partners Limited Partnership	13F Company 13F	4.4%	$93,269,000 5,260,496 shares	—	31 Dec 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

205

130,660,067

Rows available

205

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q1 2020 Across Filers

Q1 2020 holders

205

Q1 2020 holders

205

Holder diff

Investor	Q1 2020 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q1 2020 value	Value change	Value Chg %